Treatment algorithm for pulmonary arterial hypertension

KM Chin, SP Gaine, C Gerges, ZC Jing… - European …, 2024 - publications.ersnet.org
Pulmonary arterial hypertension leads to significant impairment in haemodynamics, right
heart function, exercise capacity, quality of life and survival. Current therapies have …

Pulmonary arterial hypertension: pathogenesis and clinical management

T Thenappan, ML Ormiston, JJ Ryan, SL Archer - Bmj, 2018 - bmj.com
Pulmonary hypertension is defined as a resting mean pulmonary artery pressure of 25 mm
Hg or above. This review deals with pulmonary arterial hypertension (PAH), a type of …

[HTML][HTML] 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

M Humbert, G Kovacs, MM Hoeper… - European …, 2022 - publications.ersnet.org
2022 ESC/ERS pulmonary hypertension guidelines incorporate changes and adaptations
focusing on clinical management https://bit. ly/3QtUvb4

2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of …

N Galiè, M Humbert, JL Vachiery, S Gibbs… - European heart …, 2016 - academic.oup.com
Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and can complicate the majority of cardiovascular and respiratory …

[PDF][PDF] 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

N Galiè, M Humbert, JL Vachiery… - Polish Heart …, 2015 - journals.viamedica.pl
6.2. 2. Wydolność wysiłkowa......................... 1147 6.2. 3. Markery biochemiczne........................
1147 6.2. 4. Kompleksowa ocena rokownicza i oszacowanie ryzyka........................... 1148 6.2 …

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary …

M Humbert, G Kovacs, MM Hoeper… - European heart …, 2022 - academic.oup.com
Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

Therapy for pulmonary arterial hypertension in adults: update of the CHEST guideline and expert panel report

JR Klinger, CG Elliott, DJ Levine, E Bossone, L Duvall… - Chest, 2019 - Elsevier
Background Pulmonary arterial hypertension (PAH) carries a poor prognosis if not promptly
diagnosed and appropriately treated. The development and approval of 14 medications over …

Mortality in pulmonary arterial hypertension in the modern era: early insights from the pulmonary hypertension association registry

KY Chang, S Duval, DB Badesch, TM Bull… - Journal of the …, 2022 - Am Heart Assoc
Background Current mortality data for pulmonary arterial hypertension (PAH) in the United
States are based on registries that enrolled patients prior to 2010. We sought to determine …

Pulmonary arterial hypertension: pathophysiology and treatment

NSH Lan, BD Massam, SS Kulkarni, CC Lang - Diseases, 2018 - mdpi.com
Pulmonary arterial hypertension (PAH), the first category of pulmonary hypertension, is a
chronic and progressive disorder characterised by angioproliferative vasculopathy in the …

Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data

B Thoreau, L Mouthon - Autoimmunity Reviews, 2024 - Elsevier
Pulmonary arterial hypertension (PAH), corresponding to group 1 of pulmonary
hypertension classification, is a rare disease with a major prognostic impact on morbidity …